Drugs known as SGLT2 inhibitors have been found to help treat diabetes as well as heart and kidney failure. The most common side effect of SGLT2 inhibitors is the development of genital fungal infections, whereas the most severe side effect is a serious bacterial infection of the perineum, the region between the genitals and the anus. Both types of infections are fostered by incidental contamination of the groin by glucose-rich urine.
glucaBAN is formulated to inhibit glucose-dependent microbial growth. For the patient taking SGLT2 inhibitor medications,
glucaBAN enhances freedom from odor and itching and helps control both types of microorganisms that reside in the skin.
